| 000 | 00820nam a22002537a 4500 | ||
|---|---|---|---|
| 999 |
_c5260 _d5260 |
||
| 001 | 7395 | ||
| 003 | BD-DhUAP | ||
| 005 | 20201206115823.0 | ||
| 008 | 201206s2000 nyua b 001 0 eng | ||
| 010 | _a 00024958 | ||
| 020 | _a0824702492 | ||
| 040 |
_aDLC _cDLC _dBD-DhUAP _bEng |
||
| 082 | 0 | 0 |
_223 _a615.19 BIO |
| 245 | 0 | 0 |
_aBiopharmaceutical process validation / _cedited by Gail Sofer and Dane W. Zabriskie. |
| 260 |
_aNew York : _bMarcel Dekker, _cc2000. |
||
| 300 |
_axiv, 382 pages : _billustrations ; _c24 cm. |
||
| 490 |
_aBiotechnology and bioprocessing series ; _v25. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aPharmaceutical biotechnology _xQuality control. |
|
| 650 | 0 | _aBiopharmaceutics. | |
| 700 | 1 | _aSofer, G. K. | |
| 700 | 1 | _aZabriskie, Dane W. | |
| 942 |
_2ddc _cBK |
||